Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

Jordan M. Cloyd,Matthew Harold Katz,Laura Reka Prakash,Gauri R. Varadhachary,Robert A. Wolff,Rachna T. Shroff,Milind Javle,David R. Fogelman,Michael J. Overman,Christopher H. Crane,Eugene J. Koay,Prajnan Das,Sunil Krishnan,Bruce D. Minsky,Jeffrey H. Lee,Manoop S. Bhutani,Brian Weston,William A. Ross,Priya R Bhosale,Eric P. Tamm,Huamin Wang,Anirban Maitra,Michael P. Kim,Thomas A. Aloia,J. N. Vauthey,Jason B. Fleming,James L. Abbruzzese,Peter W Pisters,Douglas B. Evans,Jeffrey E. Lee

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

2017

Background The purpose of this study was to evaluate a single-institution experience with delivery of preoperative therapy to patients with pancreatic ductal adenocarcinoma (PDAC) prior to pancreatoduodenectomy (PD).

Keywords:

Surgery
Neoadjuvant therapy
Pancreatectomy
General surgery
Preoperative Therapy
Adenocarcinoma
Medicine
pancreatic ductal adenocarcinoma
single institution

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations